Med Lett Drugs Ther. 2010 Nov 15;52(1351):91-2.
The FDA has approved the marketing of an extended-release formulation of trazodone (Oleptro--Angelini Labopharm) for treatment of major depressive disorder in adults. Immediate-release trazodone has been available for treatment of depression for many years, but is used mostly in low doses for its sedating effects.
美国食品药品监督管理局（FDA）已批准曲唑酮缓释制剂（Oleptro--安吉利尼制药公司）上市，用于治疗成人重度抑郁症。速释型曲唑酮用于治疗抑郁症已有多年，但大多以低剂量使用，利用其镇静作用。
